vs

Side-by-side financial comparison of Traeger, Inc. (COOK) and TransMedics Group, Inc. (TMDX). Click either name above to swap in a different company.

TransMedics Group, Inc. is the larger business by last-quarter revenue ($160.8M vs $145.4M, roughly 1.1× Traeger, Inc.). TransMedics Group, Inc. runs the higher net margin — 65.6% vs -11.8%, a 77.4% gap on every dollar of revenue. On growth, TransMedics Group, Inc. posted the faster year-over-year revenue change (32.2% vs -13.8%). TransMedics Group, Inc. produced more free cash flow last quarter ($19.0M vs $14.2M). Over the past eight quarters, TransMedics Group, Inc.'s revenue compounded faster (28.8% CAGR vs 0.2%).

Traeger, Inc. designs, manufactures, and sells premium wood pellet grills, related accessories, and wood pellet fuel for outdoor cooking users. It primarily operates in North America, Europe, and Australia, serving residential consumers and commercial food service clients via retail partners and direct-to-consumer channels.

TransMedics Group, Inc. develops and commercializes innovative medical technologies for organ transplantation. Its flagship Organ Care System keeps donor organs viable during transport, improving transplant outcomes for heart, lung, liver and kidney recipients. It serves transplant centers and organ procurement organizations across North America, Europe and Asia-Pacific.

COOK vs TMDX — Head-to-Head

Bigger by revenue
TMDX
TMDX
1.1× larger
TMDX
$160.8M
$145.4M
COOK
Growing faster (revenue YoY)
TMDX
TMDX
+46.0% gap
TMDX
32.2%
-13.8%
COOK
Higher net margin
TMDX
TMDX
77.4% more per $
TMDX
65.6%
-11.8%
COOK
More free cash flow
TMDX
TMDX
$4.8M more FCF
TMDX
$19.0M
$14.2M
COOK
Faster 2-yr revenue CAGR
TMDX
TMDX
Annualised
TMDX
28.8%
0.2%
COOK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COOK
COOK
TMDX
TMDX
Revenue
$145.4M
$160.8M
Net Profit
$-17.2M
$105.4M
Gross Margin
37.4%
58.1%
Operating Margin
-8.0%
13.2%
Net Margin
-11.8%
65.6%
Revenue YoY
-13.8%
32.2%
Net Profit YoY
-147.2%
1436.9%
EPS (diluted)
$-0.13
$2.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COOK
COOK
TMDX
TMDX
Q4 25
$145.4M
$160.8M
Q3 25
$125.4M
$143.8M
Q2 25
$145.5M
$157.4M
Q1 25
$143.3M
$143.5M
Q4 24
$168.6M
$121.6M
Q3 24
$122.0M
$108.8M
Q2 24
$168.5M
$114.3M
Q1 24
$144.9M
$96.8M
Net Profit
COOK
COOK
TMDX
TMDX
Q4 25
$-17.2M
$105.4M
Q3 25
$-89.8M
$24.3M
Q2 25
$-7.4M
$34.9M
Q1 25
$-778.0K
$25.7M
Q4 24
$-7.0M
$6.9M
Q3 24
$-19.8M
$4.2M
Q2 24
$-2.6M
$12.2M
Q1 24
$-4.7M
$12.2M
Gross Margin
COOK
COOK
TMDX
TMDX
Q4 25
37.4%
58.1%
Q3 25
38.7%
58.8%
Q2 25
39.2%
61.4%
Q1 25
41.5%
61.5%
Q4 24
40.9%
59.2%
Q3 24
42.3%
55.9%
Q2 24
42.9%
60.6%
Q1 24
43.2%
61.9%
Operating Margin
COOK
COOK
TMDX
TMDX
Q4 25
-8.0%
13.2%
Q3 25
-66.5%
16.2%
Q2 25
-4.2%
23.2%
Q1 25
2.4%
19.1%
Q4 24
-0.1%
7.1%
Q3 24
-6.1%
3.6%
Q2 24
2.8%
10.9%
Q1 24
-0.1%
12.8%
Net Margin
COOK
COOK
TMDX
TMDX
Q4 25
-11.8%
65.6%
Q3 25
-71.6%
16.9%
Q2 25
-5.1%
22.2%
Q1 25
-0.5%
17.9%
Q4 24
-4.1%
5.6%
Q3 24
-16.2%
3.9%
Q2 24
-1.5%
10.7%
Q1 24
-3.2%
12.6%
EPS (diluted)
COOK
COOK
TMDX
TMDX
Q4 25
$-0.13
$2.59
Q3 25
$-0.67
$0.66
Q2 25
$-0.06
$0.92
Q1 25
$-0.01
$0.70
Q4 24
$-0.06
$0.19
Q3 24
$-0.15
$0.12
Q2 24
$-0.02
$0.35
Q1 24
$-0.04
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COOK
COOK
TMDX
TMDX
Cash + ST InvestmentsLiquidity on hand
$19.6M
Total DebtLower is stronger
$403.3M
Stockholders' EquityBook value
$170.8M
$473.1M
Total Assets
$676.0M
$1.1B
Debt / EquityLower = less leverage
2.36×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COOK
COOK
TMDX
TMDX
Q4 25
$19.6M
Q3 25
$5.9M
Q2 25
$10.3M
Q1 25
$12.0M
Q4 24
$15.0M
Q3 24
$16.9M
$330.1M
Q2 24
$18.0M
$362.8M
Q1 24
$23.6M
$350.2M
Total Debt
COOK
COOK
TMDX
TMDX
Q4 25
$403.3M
Q3 25
Q2 25
Q1 25
Q4 24
$403.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
COOK
COOK
TMDX
TMDX
Q4 25
$170.8M
$473.1M
Q3 25
$186.1M
$355.2M
Q2 25
$274.2M
$318.1M
Q1 25
$279.6M
$266.3M
Q4 24
$276.4M
$228.6M
Q3 24
$279.8M
$209.9M
Q2 24
$297.3M
$189.9M
Q1 24
$294.6M
$159.5M
Total Assets
COOK
COOK
TMDX
TMDX
Q4 25
$676.0M
$1.1B
Q3 25
$689.6M
$946.0M
Q2 25
$780.6M
$890.5M
Q1 25
$825.6M
$837.5M
Q4 24
$830.7M
$804.1M
Q3 24
$818.1M
$785.6M
Q2 24
$842.4M
$758.6M
Q1 24
$862.1M
$723.8M
Debt / Equity
COOK
COOK
TMDX
TMDX
Q4 25
2.36×
Q3 25
Q2 25
Q1 25
Q4 24
1.46×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COOK
COOK
TMDX
TMDX
Operating Cash FlowLast quarter
$15.5M
$34.5M
Free Cash FlowOCF − Capex
$14.2M
$19.0M
FCF MarginFCF / Revenue
9.8%
11.8%
Capex IntensityCapex / Revenue
0.9%
9.7%
Cash ConversionOCF / Net Profit
0.33×
TTM Free Cash FlowTrailing 4 quarters
$13.6M
$133.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COOK
COOK
TMDX
TMDX
Q4 25
$15.5M
$34.5M
Q3 25
$7.6M
$69.6M
Q2 25
$18.3M
$91.6M
Q1 25
$-20.8M
$-2.9M
Q4 24
$7.5M
$19.7M
Q3 24
$15.1M
$6.9M
Q2 24
$13.9M
$25.7M
Q1 24
$-12.6M
$-3.4M
Free Cash Flow
COOK
COOK
TMDX
TMDX
Q4 25
$14.2M
$19.0M
Q3 25
$6.4M
$61.9M
Q2 25
$15.7M
$82.5M
Q1 25
$-22.7M
$-29.9M
Q4 24
$5.5M
$6.1M
Q3 24
$12.8M
$-41.3M
Q2 24
$11.8M
$2.0M
Q1 24
$-18.3M
$-47.6M
FCF Margin
COOK
COOK
TMDX
TMDX
Q4 25
9.8%
11.8%
Q3 25
5.1%
43.1%
Q2 25
10.8%
52.4%
Q1 25
-15.8%
-20.8%
Q4 24
3.3%
5.0%
Q3 24
10.5%
-38.0%
Q2 24
7.0%
1.7%
Q1 24
-12.6%
-49.2%
Capex Intensity
COOK
COOK
TMDX
TMDX
Q4 25
0.9%
9.7%
Q3 25
0.9%
5.3%
Q2 25
1.8%
5.8%
Q1 25
1.3%
18.8%
Q4 24
1.2%
11.2%
Q3 24
1.9%
44.3%
Q2 24
1.2%
20.8%
Q1 24
3.9%
45.6%
Cash Conversion
COOK
COOK
TMDX
TMDX
Q4 25
0.33×
Q3 25
2.86×
Q2 25
2.62×
Q1 25
-0.11×
Q4 24
2.87×
Q3 24
1.63×
Q2 24
2.11×
Q1 24
-0.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COOK
COOK

Grills$60.6M42%
Accessories$49.2M34%
Consumables$35.5M24%

TMDX
TMDX

Liver Product$127.0M79%
Heart Product$26.0M16%
Other$5.9M4%
Lung Product$1.9M1%

Related Comparisons